Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
3
×
amgen
eli lilly
fda
migraine
new york blog main
raleigh-durham blog main
raleigh-durham top stories
abbvie
acute migrane
allergan
alprazolam
bain capital
bausch health
biohaven
boston blog main
breast cancer
cgpr
cgrp inhibitors
chronic migraine
colucid pharmaceuticals
desmoid tumor
dihydroergotamine
dihydroergotamine mesylate
drug enforcement administration
europe blog main
generic drug
glaxosmithkline
impel neuropharma
indiana
indiana blog main
indiana top stories
lasmiditan
medical device
merck
migraine research foundation
multiple myeloma
What
migraine
3
×
drug
fda
new
activity
acute
addresses
adults
allergan
approval
approved
biotech
causes
class
companies
condition
days
decades
dog
eli
firm
friday
giant
giving
hasn’t
ipo
ipos
lasmiditan
leading
lilly
lilly’s
line
medication
medicines
monday
nod
oks
pfizer
pharmaceutical
pill
Language
unset
3
×
Current search:
migraine
×
unset
×
" national blog main "
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
